Director/PDMR Shareholding

CVS

11/07/2025 15:48

RNS Number : 8003Q

CVS Group plc

11 July 2025

 

11 July 2025

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 11 July 2025 that Richard Fairman, Chief Executive Officer of the Company, purchased a total of 1,644 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, Richard Fairman's total interest in the Company, including all persons closely associated, is now at 79,751 Ordinary Shares, representing 0.111% per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc                                                                                                                                via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)                                                      +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

   Berenberg (Joint Broker)                                                                                          +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial PR)                                                                                             

Geoffrey Pelham-Lane                                                                                                +44 (0)7733 124 226

Ginny Pulbrook                                                                                                           +44 (0)7961 315 138

    

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Richard Fairman
2
Reason for the notification
a)
Position/status
PDMR (CEO)
b)
Initial notification /Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
CVS Group plc
b)
LEI
213800J41XDQ2NX48O05
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 0.2 pence each
GB00B2863827
b)
Nature of the transaction
On-market purchase
c)
Price(s) and volume(s)
Price(s) - pence
Volume(s)
1,216.00
1,644
d)
Aggregated information
- Aggregated volume
- Price
N/A - single transaction
e)
Date of the transaction
11 July 2025
f)
Place of the transaction
London Stock Exchange - AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHEALXFFLXSEFA